Status:
COMPLETED
COVID-19 Seroprevalence in Pregnant Women and Blood Donors
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
COVID-19 Respiratory Infection
Eligibility:
All Genders
18-70 years
Brief Summary
The study aims to measure the SARS-CoV-2 seroprevalence (ie. the proportion of people with antibodies against the virus) in pregnant women and blood donors in an administrative area of France, and to ...
Eligibility Criteria
Inclusion
- Pregnant women
- Adult female
- Admitted to hospital for live birth
- Informed consent
- Affiliated to the French social security health insurance scheme
- Blood donors
- Adult male or female
- Qualified for whole blood donation (up to 70 years old in France)
- Informed consent
- Affiliated to the French social security health insurance scheme
Exclusion
- Legal incapacity or limited legal capacity
- Subject without health insurance coverage
- Exclusion period of another study or exclusion period of the French national healthy volunteer registry
Key Trial Info
Start Date :
September 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 4 2023
Estimated Enrollment :
797 Patients enrolled
Trial Details
Trial ID
NCT04893057
Start Date
September 15 2022
End Date
January 4 2023
Last Update
October 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de besançon
Besançon, France